Trial reportClinical rheumatology2025
The efficacy of a telerehabilitation-based clinical Pilates program on lumbopelvic muscle morphology and strength in female patients with fibromyalgia syndrome: a randomized controlled trial.
Trial report in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Six-month supervised telerehabilitation combining pilates-based therapeutic exercise and self-myofascial release in adults with fibromyalgia: a randomized controlled trial.Journal of rehabilitation medicine · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe current study aims to assess the effects of a tele-rehabilitation-based clinical Pilates exercise program on morphological structure, endurance, central sensitization, pain, fatigue, anxiety, and depression in Fibromyalgia syndrome (FMS) patients.
methodThirty women with FMS were randomized into two groups: the telerehabilitation group (TG) or the control group (CG). An online clinical Pilates-based exercise program targeting stability and strength that was conducted for 8 weeks with 2 sessions per week was developed for TG. The same exercise programs for the CG were provided in printed brochures. Lumbopelvic muscle thickness, core endurance tests, disease activity, fatigue, central sensitization, pain, anxiety, and depression were evaluated in patients at the beginning and end of the study.
resultsDecrease in lumbopelvic muscle thickness and core endurance strength in FMS patients compared to healthy individuals (p < 0.017). There was a significant effect of group × time interaction (F = 4.900, p = 0.035; F = 5.063, p = 0.032) for external oblique (right and left, respectively), fatigue (F = 15.489, p < 0.001), central sensitization (F = 17.518, p < 0.001), anxiety (F = 8.672, p = 0.006) in favor of the TG. Significant time effects were observed across all examined outcomes, covering lumbopelvic muscle thickness, fatigue, central sensitization, anxiety, depression, and core endurance strength (p < 0.05). Following the 8-week intervention, both groups exhibited significant within-group decreases in disease activity and pain. However, the TG demonstrated significantly greater improvements in disease activity and pain compared with the CG (p < 0.05).
conclusionTelerehabilitation-based treatment programs are effective in increasing lumbopelvic muscle thickness and core muscle endurance. Accordingly, we recommend the widespread use of this innovative treatment approach in FMS. Keypoints • FMS patients indicated lower core endurance strengths compared to healthy groups • TG showed greater improvements in muscle thickness and core endurance strength • Telerehabilitation is feasible and effective for managing the complexities of FMS • The telerehabilitation program was superior and more effective than home exercises.
Indexed as
Identifiers
41053520What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.